News
Alio, Inc., a leader in AI-powered clinical-grade wearables, has announced an international study aimed at extending its technology beyond the dialysis field. The CAVA protocol will evaluate Alio?s FDA-cleared SmartPatch technology
Read more...12 September 2024
Proprio, a leading innovator in AI-powered surgical technology, has achieved a significant milestone with its cutting-edge surgical guidance platform, Paradigm, completing 50 successful surgeries.
Read more...12 September 2024
Signet Healthcare Partners ("Signet") is pleased to announce that Paragonix Technologies ("Paragonix" or the "Company"), a leader in organ transplantation and preservation technology,
Read more...11 September 2024
IR-MED, a developer of non-invasive, AI-driven spectrographic technology, has launched an evaluation of its PressureSafe? device at Methodist Healthcare in San Antonio, Texas.
Read more...11 September 2024
Bearpac Medical, LLC has launched the AESOP clinical trial, which stands for Assessing Experience, Safety, and Outcomes of the Passio Pump Drainage System. This single-center, crossover, non-blinded
Read more...10 September 2024
DeepWell Digital Therapeutics (DTx) has secured FDA 510(k) clearance for its technology designed for use in immersive media, such as video games, focusing on stress reduction
Read more...10 September 2024
XRP Healthcare is advancing the integration of artificial intelligence (AI) and blockchain technology in the healthcare sector with the introduction of the XRPH AI Chatbot. This new
Read more...DeepHealth, a subsidiary of RadNet, and a leader in AI-driven radiology and health informatics, has partnered with HOPPR (www.hoppr.ai) to advance AI technologies.
Read more...Forma Medical,?a leader in innovative orthopedic solutions, is excited to announce the successful treatment of its 15th patient using the OptimalMTP system.
Read more...MicroPort? CardioFlow Speeds Up Commercial Launch of AnchorMan? Left Atrial Appendage Closure System
6 September 2024
MicroPort? CardioFlow Medtech Corporation has announced that its subsidiary, MicroPort? CardioAdvent, is advancing the clinical use of its independently developed AnchorMan? Left Atrial Appendage (LAA) Closure System
Read more...